A neurosurgeon's view: Outcome after RF-ablation for mTLE

Hana Malikova1, Roman Liscak2

  • 1Department of Stereotactic and Radiation Neurosurgery, Na Homolce Hospital, Prague, Czech Republic; Radiology Department, Faculty Hospital Kralovske Vinohrady and Third Medical Faculty of Charles University, Prague, Czech Republic.

Epilepsy Research
|September 3, 2017
PubMed

Insights

Radiofrequency ablation (RF-ablation) for mesial temporal lobe epilepsy (mTLE) offers a minimally invasive stereotactic technique. This procedure achieved long-term seizure freedom in 71% of patients with a low complication rate.

Area of Science:

  • Neurosurgery
  • Epilepsy Research
  • Minimally Invasive Procedures

Background:

  • Mesial temporal lobe epilepsy (mTLE) is a common form of drug-resistant epilepsy.
  • Surgical interventions are considered for refractory cases, with open surgery being a traditional option.
  • Radiofrequency ablation (RF-ablation) presents a less invasive alternative.

Purpose of the Study:

  • To review the current radiofrequency ablation (RF-ablation) technique for mesial temporal lobe epilepsy (mTLE).
  • To evaluate the complications associated with RF-ablation for mTLE.
  • To compare the clinical outcomes of RF-ablation with open surgical techniques.

Main Methods:

  • Review of current radiofrequency ablation (RF-ablation) techniques for mTLE.
  • Stereotactic approach targeting the amygdalohippocampal complex (AHC).
  • Occipital access with thermolesion creation along the AHC's long axis under local anesthesia.

Main Results:

  • RF-ablation of the amygdalohippocampal complex (AHC) achieved long-term seizure-free outcomes in 71% of mTLE patients.
  • The technique demonstrated a low rate of complications.
  • Clinical seizure outcomes appear comparable to those of open surgical methods.

Conclusions:

  • RF-ablation is an effective stereotactic technique for managing mTLE.
  • The procedure offers a favorable safety profile with outcomes comparable to open surgery.
  • RF-ablation represents a viable, minimally invasive surgical option for selected mTLE patients.

Related Concept Videos